Amazon-Vended Vegetable Chips Recalled Over Undeclared Gluten, FDA Warns

A vegetable chip product distributed to U.S. consumers through Amazon has been voluntarily recalled by Exotique Foods Inc. of Ontario, Canada, due to the potential presence of undeclared gluten. This poses a serious health risk to individuals with celiac disease, an autoimmune disorder in which gluten consumption triggers intestinal damage. The U.S. Food and Drug Administration (FDA) published its recall notification on Wednesday, following the company’s initial announcement made five days earlier. The affected product, Momchipz Veggie Chips Broccoli Florets and Cauliflower, was sold to 49 U.S. customers via Amazon.com between March and June of this year.

Importantly, the recalled items remain within their shelf life, as the best-before date is listed as August 31, 2026—meaning unopened packages may still be present in consumer pantries. The product is sold in 3-ounce (85-gram) bags, identifiable solely by its UPC code: 6 28634 44216 6 and the printed best-before date of 2026 AUGUST 31. Notably, there is no batch or lot number associated with the recall, and visually, these bags cannot be distinguished from unaffected ones. The FDA notice applies specifically to this single product variant and size.

The FDA reports no confirmed illnesses related to this recall at this time. However, the Canadian Food Inspection Agency (CFIA) documented one reported adverse reaction linked to consumption of the product. Individuals with celiac disease or those with a severe sensitivity to gluten are advised to avoid consuming the product and may dispose of it or seek a full refund from the point of purchase. For further inquiries, Exotique Foods Inc. can be reached at 1-647-528-7080, Monday through Thursday, from 9 a.m. to noon Eastern Time.

Challenges in Tracking Direct-to-Consumer Sales

The relatively small scale of this recall—49 affected units—adds complexity compared to typical store-based recalls. Retailers often use loyalty card data to alert shoppers, post in-store signage, and engage staff to intercept sales. In contrast, online orders lack these physical touchpoints, leaving consumers to rely on digital order histories or proactive monitoring of recall notices—channels that are rarely checked regularly. As e-commerce expands, so does the gap between product distribution methods and traditional food safety communication infrastructure.

For households managing celiac disease or gluten sensitivities, experts recommend periodically reviewing past online grocery purchases and setting alerts for recalled brands. Unlike grocery store recalls, many entries on the FDA’s public recalls and safety alerts webpage reflect company-initiated notifications rather than automated warnings pushed directly to buyers.

Celiac Disease and the Critical Role of Accurate Labeling

Celiac disease affects approximately one in 100 people globally and is triggered by the ingestion of gluten, a protein found in wheat, barley, and rye. The condition leads to immune-mediated damage to the small intestine and requires strict, lifelong adherence to a gluten-free diet. For these individuals, accurate ingredient labeling isn’t just a matter of preference—it’s essential for maintaining health.

An undeclared source of gluten presents unique risks. There is no safe threshold for consumption, and symptoms can manifest without warning. Common reactions include gastrointestinal distress such as diarrhea, bloating, nausea, and abdominal pain, while others may experience non-digestive effects like fatigue, headaches, joint pain, or skinconditions such as dermatitis herpetiformis. Because symptoms vary widely and can occur in the absence of obvious signs, exposure is frequently underreported.

While most acute exposures do not necessitate emergency treatment, persistent or severe symptoms should prompt consultation with a healthcare provider. Those with a diagnosed wheat allergy—distinct from celiac disease—may experience more urgent allergic responses, including swelling of the throat or difficulty breathing, which require immediate medical attention.

Those concerned about possible undiagnosed celiac disease should consult a clinician before eliminating gluten from their diet, as diagnostic tests like serological screening and intestinal biopsy require ongoing gluten intake for accuracy. Premature dietary changes may lead to false-negative results.

Additionally, cost considerations influence consumer choices. Certified gluten-free products often carry higher prices, pushing budget-conscious families toward perceived “healthier” alternatives labeled as vegetable-based snacks. Such assumptions are challenged when contamination occurs in products seemingly designed for safe consumption, highlighting the vulnerability created by labeling inaccuracies.

Discrepancies in Recall Origins

There appears to be some inconsistency in how the recall was initiated according to regulatory disclosures. According to the FDA, the recall was prompted by a positive result from a retail sample supplied by the CFIA. Meanwhile, the CFIA states that the recall originated from a consumer complaint. While these pathways aren’t mutually exclusive—a complaint could trigger follow-up testing—the timelines and causal links have not been clarified publicly. The Canadian notice was issued on August 7, preceding the broader company announcement affecting U.S. buyers by roughly one week.

The CFIA categorized the recall as Class 2, indicating low-to-moderate risk and typically involving substances that might cause temporary or reversible health effects. It assigned the case identifier RA-82462 and confirmed that its ongoing investigation may expand the scope of the recall to include additional products, though no others have yet been named.

To date, neither agency has disclosed how gluten contamination entered a product formulated primarily from vegetables, nor whether cross-contamination during manufacturing or the use of contaminated ingredients was responsible. Further updates will be provided should new findings emerge from either party’s investigation.

Key Questions Answered

Which product is recalled? Momchipz Veggie Chips Broccoli Florets and Cauliflower, packaged in 3 ounces (85 grams), with UPC 6 28634 44216 6 and a best-before date of August 31, 2026.

Where was it sold in the United States? It was distributed to 49 individual customers through Amazon.com between March and June 2024.

Can the product still be consumed safely? Although the best-before date has not passed, anyone with celiac disease or gluten sensitivity should not consume the product due to the risk of undeclared gluten exposure.

Were any illnesses reported? No illnesses were reported in the FDA’s notice. The Canadian Food Inspection Agency noted one suspected adverse reaction associated with the product.

Who is most at risk? People diagnosed with celiac disease or other forms of gluten-related disorders are at highest risk. Individuals with a confirmed wheat allergy may also face a heightened chance of an allergic reaction.

What should I do if I consumed the product? Most instances of accidental exposure do not require emergency care. Seek medical advice if you develop symptoms such as persistent digestive upset, skin rashes, or joint pain. Immediate care is needed for signs of an allergic reaction like throat tightness or breathing difficulties.

Might the recall expand beyond this item? Possibly. The CFIA has indicated that its investigation is ongoing and may result in additional recalls if similar issues are identified in other products.

Source link